Prevalence of Anti-RNA Polymerase III Antibodies in Systemic Sclerosis New Data From a French Cohort and a Systematic Review and Meta-Analysis

摘要

Objective. Studies assessing the prevalence of anti-RNA polymerase III (anti-RNAP III) antibodies in systemic sclerosis (SSc) have yielded a wide range of results. The aim of the present study was to describe a new SSc cohort tested for presence of anti-RNAP III and perform a systematic review and meta-analysis to assess the prevalence of anti-RNAP III in patients worldwide and the potential factors of variability.